Inflammation-diminishing and pain-relieving ointment and preparation method thereof
Through the combination of medicinal materials such as keel, cabbage, borneol, myrrh and mixed fatty acid glycerides, an anti-inflammatory and pain relief cream suitable for anal diseases was prepared, which solved the poor efficacy and irritation problems of existing hemorrhoid drugs, and achieved the It has a short course of treatment and good anti-inflammatory and pain-relieving effect, and has no obvious toxicity or irritation.
Patent Information
- Application Number
- CN202411003988.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-25
- Publication Date
- 2024-12-03
AI Technical Summary
The existing hemorrhoid drugs have poor efficacy, long course of treatment, and some of them are irritating, causing pain in patients, or the course of treatment is short but high cost, which cannot effectively solve the pain problems of anal diseases such as anal fissures, internal hemorrhoids, mixed hemorrhoids, anal fistulas, etc.
Use keel, cabbage, borneol, myrrh, frankincense, blood dysfunction, gardenia, ginkgo leaves and other medicinal materials, combined with mixed fatty acid glycerides as the matrix, and prepare anti-inflammatory and pain relief cream through crushing, heating and stirring, and use it for the anus. Treatment of diseases.
It has achieved a short course of treatment and good efficacy against inflammation and pain relief, without adverse reactions, and is suitable for anal diseases such as anal fissures, internal hemorrhoids, mixed hemorrhoids, anal fistulas, or postoperative hemorrhoids, and has high safety and tolerance.
Smart Images

Figure CN119055720A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of Chinese herbal medicines, in particular to an anti-inflammatory and analgesic ointment and a preparation method thereof. Background Art
[0002] Traditional Chinese medicine ointment is a method of treating patients through the external application of traditional Chinese medicine. It uses a variety of medicinal materials to cooperate with each other to form a compound of multiple medicines to exert the good effects of the medicine. At present, there are many drugs used to treat hemorrhoids. The plaster is used externally to reduce inflammation, relieve pain, and promote blood circulation and remove blood stasis. The attachment of the plaster can stimulate nerve endings, dilate blood vessels through reflexes, promote local blood circulation, improve the nutrition of surrounding tissues, and achieve the purpose of reducing swelling, reducing inflammation and relieving pain. Most of the existing hemorrhoid medicines have poor efficacy and a long course of treatment. Some medicines have a certain stimulating effect, which will cause unbearable pain to patients. Some medicines have the advantages of a short course of treatment and good efficacy, but the cost is relatively high. Summary of the invention
[0003] The technical problem to be solved by the present invention is to overcome the existing defects and provide an anti-inflammatory and analgesic ointment with a unique prescription composition. It can be used for anal diseases such as anal fissures, internal hemorrhoids, mixed hemorrhoids, anal fistulas, or postoperative bleeding and pain. It has a short course of treatment, good efficacy, and no adverse reactions, and can effectively solve the problems in the background technology.
[0004] To achieve the above object, the present invention provides the following technical solutions:
[0005] The invention discloses an anti-inflammatory and analgesic ointment, wherein the weight ratio of the medicinal raw materials of the anti-inflammatory and analgesic ointment is: 45-55g of dragon bone, 45-55g of catechu, 20-30g of borneol, 25g of myrrh, 20-30g of frankincense (processed), 25-35g of dragon blood, 10-15g of gardenia and 10-15g of ginkgo leaf.
[0006] As a preferred technical solution of the present invention, the weight ratio of the medicinal raw materials of the anti-inflammatory and analgesic ointment is: 50g of dragon bone, 50g of catechu, 25g of borneol, 25g of myrrh, 25g of frankincense (processed), 30g of dragon blood, 10-15g of gardenia, and 10-15g of ginkgo leaf.
[0007] As a preferred technical solution of the present invention, the weight ratio of the medicinal raw materials of the anti-inflammatory and analgesic ointment is: 50g of dragon bone, 50g of catechu, 25g of borneol, 25g of myrrh, 25g of frankincense (processed), 30g of dragon blood, 12g of gardenia, and 12g of ginkgo leaf.
[0008] As a preferred technical solution of the present invention, the matrix of the anti-inflammatory and analgesic ointment is mixed fatty acid glyceride.
[0009] The efficacy of each component of the medicinal raw material used to prepare the anti-inflammatory and analgesic ointment of the present invention is:
[0010] Xuejie: sweet, salty and neutral in nature; enters the heart and liver meridians; functions and indications: promoting blood circulation and relieving pain, removing blood stasis and stopping bleeding, healing sores and promoting tissue regeneration; used for traumatic injuries, heart and abdominal pain, bleeding from trauma, sores that do not heal
[0011] Frankincense: pungent, bitter, warm in nature; enters the heart, liver, and spleen meridians; functions and indications: regulating qi and activating blood circulation, relieving pain, and expelling toxins; treats qi and blood stagnation, heart and abdominal pain, carbuncle swelling, traumatic injury, dysmenorrhea, and postpartum blood stasis and stabbing pain;
[0012] Myrrh: bitter and pungent, neutral in nature, non-toxic, enters the twelve meridians, functions and indications: dispersing blood and removing blood stasis, reducing swelling and relieving pain; treating falls, wounds, tendons and bones, pain in the heart and abdomen, masses, amenorrhea, swelling and pain in carbuncle, hemorrhoid fistula, and eye disorders;
[0013] Catechu: bitter, astringent, slightly cold; enters the lung meridian; functions and indications: absorbs dampness, promotes tissue regeneration, and heals sores. Used for ulcers that do not heal, eczema, mouth sores, pain from falls, and bleeding from trauma;
[0014] Borneol: pungent and bitter in taste, slightly cold in nature, enters the heart, spleen and lung meridians, functions and indications: open all orifices, disperse stagnant fire, remove cataracts and improve eyesight, reduce swelling and relieve pain; treat lockjaw caused by stroke, coma caused by fever, epilepsy, phlegm, qi stagnation and deafness, throat paralysis, mouth sores, otitis media, carbuncle, hemorrhoids, conjunctivitis and cataracts, and pinworm disease;
[0015] Dragon bone: bitter, neutral in nature; enters the liver and lung meridians; functions and indications: dispel wind and dampness, promote blood circulation and dredge collaterals, relieve cough; used for rheumatism, numbness of limbs, chest pain, heart pain, chronic tracheitis, traumatic injury, malarial disease, carbuncle;
[0016] Gardenia: bitter, cold in nature; enters the heart, liver, lung, and stomach meridians; functions and indications: purging fire and relieving restlessness, clearing away heat and dampness, cooling blood and detoxifying, dispersing blood stasis and relieving swelling, used to treat restlessness due to febrile diseases, red eyes due to liver fire, headache, jaundice due to damp heat, stranguria, epistaxis due to leaf blood, bloody diarrhea and hematuria, oral sores, sores and swelling, and sprains and swelling;
[0017] Ginkgo leaf: flavor and nature: bitter; sweet; astringent; neutral; meridians entered: heart; lung; spleen; invigorates blood circulation and nourishes the heart, astringes the lungs and astringes the intestines; treats chest pain; asthma, cough, phlegm and cough; diarrhea, dysentery and leucorrhea.
[0018] The preparation method of the anti-inflammatory and analgesic ointment comprises the following steps:
[0019] Step 1: grind dragon bone, catechu, borneol, myrrh, frankincense (processed), dragon's blood, gardenia, and ginkgo leaf into fine powder respectively, and set aside for later use;
[0020] Step 2: Take the eight Chinese medicinal herbs crushed into fine powder in step 1 according to the proportions and mix them evenly;
[0021] Step 3: Heat the mixed fatty acid glyceride, filter it when it is heated to about 120° C., and place it aside or cool it down physically;
[0022] Step 4: When the temperature of the mixed fatty acid glyceride after heating and filtration in step 3 drops to about 50° C., the mixed fatty acid glyceride is mixed again with the powder mixed evenly in step 2 according to a certain ratio, and stirred evenly;
[0023] Step 5: Pour the mixture of the matrix and the powder mixed and stirred evenly in step 4 into the suppository mold coated with lubricant and cool it. After cooling, scrape off the overflowed part, open the mold and take out the suppository, and the production of the anti-inflammatory and analgesic ointment is completed.
[0024] As a preferred technical solution of the present invention, the mixing ratio of the mixed fatty acid glyceride and the powder mixed evenly in step 2 is 17:3.
[0025] As a preferred technical solution of the present invention, the anti-inflammatory and analgesic ointment prepared in step five is an ointment.
[0026] Compared with the prior art, the present invention has the following beneficial effects:
[0027] This anti-inflammatory and analgesic ointment has a unique prescription composition and can be used for anal diseases such as anal fissures, internal hemorrhoids, mixed hemorrhoids, anal fistulas, or postoperative bleeding and pain. It has a short course of treatment, good efficacy, and no adverse reactions. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] Figure 1 It is a schematic diagram of the preparation process of the present invention. DETAILED DESCRIPTION
[0029] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0030] Example 1
[0031] See also Figure 1 , the present invention provides a technical solution:
[0032] The invention discloses an anti-inflammatory and analgesic ointment, wherein the weight ratio of the medicinal raw materials of the anti-inflammatory and analgesic ointment is: 50g of dragon bone, 50g of catechu, 25g of borneol, 25g of myrrh, 25g of frankincense (processed), 30g of dragon blood, 12g of gardenia and 12g of ginkgo leaf.
[0033] The base of the anti-inflammatory and analgesic ointment is mixed fatty acid glycerides.
[0034] The preparation method of the anti-inflammatory and analgesic ointment comprises the following steps:
[0035] Step 1: grind 50g bone, 50g catechu, 25g borneol, 25g myrrh, 25g frankincense (processed), 30g dragon's blood, 12g gardenia, and 12g ginkgo leaf into fine powder respectively, and set aside;
[0036] Step 2: Take the eight Chinese medicinal herbs crushed into fine powder in step 1 according to the proportions and mix them evenly;
[0037] Step 3: Heat the mixed fatty acid glyceride, filter it when it is heated to about 120° C., and place it aside or cool it down physically;
[0038] Step 4: When the temperature of the mixed fatty acid glyceride after heating and filtration in step 3 drops to about 50° C., the mixed fatty acid glyceride is mixed again with the powder mixed evenly in step 2 according to a certain ratio, and stirred evenly;
[0039] Step 5: Pour the mixture of the matrix and the powder mixed and stirred evenly in step 4 into the suppository mold coated with lubricant and cool it. After cooling, scrape off the overflowed part, open the mold and take out the suppository, and the production of the anti-inflammatory and analgesic ointment is completed.
[0040] The mixing ratio of the mixed fatty acid glyceride to the powder mixed evenly in step 2 is 17:3.
[0041] The anti-inflammatory and analgesic ointment prepared in step five is an ointment.
[0042] Example 2
[0043] See also Figure 1 , the present invention provides a technical solution:
[0044] The invention discloses an anti-inflammatory and analgesic ointment, wherein the weight ratio of the medicinal raw materials of the anti-inflammatory and analgesic ointment is: 45g of dragon bone, 45g of catechu, 20g of borneol, 25g of myrrh, 20g of frankincense (processed), 25g of dragon blood, 10g of gardenia and 10g of ginkgo leaf.
[0045] The base of the anti-inflammatory and analgesic ointment is mixed fatty acid glycerides.
[0046] The preparation method of the anti-inflammatory and analgesic ointment comprises the following steps:
[0047] Step 1: grind 45g of dragon bone, 45g of catechu, 20g of borneol, 25g of myrrh, 20g of frankincense (processed), 25g of dragon blood, 10g of gardenia, and 10g of ginkgo leaf into fine powder respectively, and set aside;
[0048] Step 2: Take the eight Chinese medicinal herbs crushed into fine powder in step 1 according to the proportions and mix them evenly;
[0049] Step 3: Heat the mixed fatty acid glyceride, filter it when it is heated to about 120° C., and place it aside or cool it down physically;
[0050] Step 4: When the temperature of the mixed fatty acid glyceride after heating and filtration in step 3 drops to about 50° C., the mixed fatty acid glyceride is mixed again with the powder mixed evenly in step 2 according to a certain ratio, and stirred evenly;
[0051] Step 5: Pour the mixture of the matrix and the powder mixed and stirred evenly in step 4 into the suppository mold coated with lubricant and cool it. After cooling, scrape off the overflowed part, open the mold and take out the suppository, and the production of the anti-inflammatory and analgesic ointment is completed.
[0052] The mixing ratio of the mixed fatty acid glyceride to the powder mixed evenly in step 2 is 17:3.
[0053] The anti-inflammatory and analgesic ointment prepared in step five is an ointment.
[0054] Example 3
[0055] See also Figure 1 , the present invention provides a technical solution:
[0056] The invention discloses an anti-inflammatory and analgesic ointment, wherein the weight ratio of the medicinal raw materials of the anti-inflammatory and analgesic ointment is: 55g of dragon bone, 55g of catechu, 30g of borneol, 25g of myrrh, 30g of frankincense (processed), 35g of dragon blood, 15g of gardenia and 15g of ginkgo leaf.
[0057] The base of the anti-inflammatory and analgesic ointment is mixed fatty acid glycerides.
[0058] The preparation method of the anti-inflammatory and analgesic ointment comprises the following steps:
[0059] Step 1: grind 55g of dragon bone, 55g of catechu, 30g of borneol, 25g of myrrh, 30g of frankincense (processed), 35g of dragon blood, 15g of gardenia, and 15g of ginkgo leaf into fine powder respectively, and set aside for later use;
[0060] Step 2: Take the eight Chinese medicinal herbs crushed into fine powder in step 1 according to the proportions and mix them evenly;
[0061] Step 3: Heat the mixed fatty acid glyceride, filter it when it is heated to about 120° C., and place it aside or cool it down physically;
[0062] Step 4: When the temperature of the mixed fatty acid glyceride after heating and filtration in step 3 drops to about 50° C., the mixed fatty acid glyceride is mixed again with the powder mixed evenly in step 2 according to a certain ratio, and stirred evenly;
[0063] Step 5: Pour the mixture of the matrix and the powder mixed and stirred evenly in step 4 into the suppository mold coated with lubricant and cool it. After cooling, scrape off the overflowed part, open the mold and take out the suppository, and the production of the anti-inflammatory and analgesic ointment is completed.
[0064] The mixing ratio of the mixed fatty acid glyceride to the powder mixed evenly in step 2 is 17:3.
[0065] The anti-inflammatory and analgesic ointment prepared in step five is an ointment.
[0066] During the research and development process, the invention adopts chemical and instrumental analysis methods to develop an identification method for borneol and isoborneol in borneol, and establishes a quantitative analysis standard and method for determining dragon's blood by thin-layer scanning method with dragon's blood as the main drug.
[0067] The anti-inflammatory and analgesic ointment prepared by the present invention has passed the following multiple safety tests before clinical trials:
[0068] 1. Acute toxicity test.
[0069] Experimental method: Determination of maximum tolerance by oral administration:
[0070] 100 mice, half male and half female, weighing 16-25 grams, were fasted for 24 hours before administration. 45 ml / kg suspension of the anti-inflammatory and analgesic ointment raw material drug (approximately equivalent to 9.0 g / kg of the raw drug) was administered by gavage each time. The drug was administered 3 times within 1 day, with an interval of 4 hours between each administration.
[0071] The skin, eyes, fur, activities, feeding, breathing and other changes of the mice were observed after drug administration. The surviving mice were killed and autopsied after one week.
[0072] Results: There were no abnormal reactions in the above observation indicators after administration, and no death was found after one week of feeding and observation.
[0073] The maximum tolerable dose of mice was measured to be 20.0 g / kg in this experiment, and no abnormalities were found in the autopsy of surviving mice.
[0074] In summary, the oral toxicity of the raw material of the anti-inflammatory and analgesic ointment is relatively low and can be used clinically. From the perspective of the tolerance multiple of mice, the use of suppositories of 1.2g / pill / time by adults [powder: matrix (3:17), containing 0.225g of crude drug] is equivalent to 4666.7 times the tolerance multiple of adults for a single dose.
[0075] The LD50 of oral administration could not be determined because the dose could not be increased due to limitations on drug concentration and administration volume.
[0076] 2. Safety test
[0077] 1) Rectal drug irritation test:
[0078] Test methods and results:
[0079] 40 rabbits, weighing about 2.5kg, were randomly divided into 4 groups, test group (no animal death occurred in the pre-test high-dose group) and blank suppository group, each group had 10 rabbits, fasted for 24 hours before administration, and each group was rectally administered with a dose of 2.0g / rabbit (powder: matrix (3:2) suppository (containing 1.32g of crude drug, for single large-dose rectal administration of rabbits). The test substance was in contact with the animal rectum for at least 4 hours, and the systemic condition and local irritation reaction were observed up to 24 hours after the administration of the test substance. After 24 hours, half of the animals were killed, and the rectum was taken to observe whether the mucosa had congestion, edema and other changes, and pathological histological examination was performed and compared with the control group. The systemic condition of the remaining animals was observed and recorded daily. The remaining animals were killed on the seventh day, and the changes in the rectum were examined, and pathological histological examination was performed and compared with the control group.
[0080] result:
[0081] After administration, there were no obvious abnormal reactions in the above observation indicators. After 24 hours, half of the animals were killed, and the rectum was taken. No obvious changes such as congestion and edema were found in the mucosa. There was no significant difference compared with the control group by pathological histology. After one week of feeding, no one died. The rectum was taken for macroscopic observation and pathological histology, and there was no significant difference compared with the control group. Due to the limitation of drug concentration and administration volume, the dose could not be increased. It shows that after large-dose rectal administration of rabbits, no obvious toxicity and irritation were observed.
[0082] Judging from the tolerance multiples of rabbits, if an adult uses suppository at 1.3g / pill / time (powder: matrix (3:17), containing 0.225g of crude drug), it is equivalent to 146.7 times the tolerance multiple of an adult single dose. If an adult uses it twice a day (3.0g / day, powder: matrix (3:17), containing 0.45g of crude drug), it is equivalent to 73.3 times the adult daily dose.
[0083] And conduct pathological anatomy observation. (The specimen examined is the rectal section of rabbit)
[0084] Conclusion: No specific lesions caused by this drug were found in the rectal sections of all experimental animals.
[0085] 2) Multiple rectal medication stimulation tests.
[0086] 24 rabbits, weighing about 3.0kg, were randomly divided into 2 groups: test group and blank suppository group, 12 rabbits in each group. They were fasted for 24 hours before administration. Each group was given rectal administration at a dose of 1.6g / rabbit (powder: matrix (2:3) black suppository weight = 1.5g / grain (containing 0.60g crude drug, for multiple rectal administration to rabbits). The test substance was in contact with the animal rectum for at least 4 hours. The administration was given once a day for 10 consecutive days. The systemic condition and local irritation reaction after 10 days of administration of the test substance were observed. 24 hours after the last administration, 1 / 2 of the animals were killed, and the rectum was taken to observe whether the mucosa had changes such as congestion and edema, and pathological histological examination was performed and compared with the control group. The systemic condition of the remaining animals was observed and recorded daily. The remaining animals were killed on the seventh day to examine the changes in the rectum.
[0087] result:
[0088] After administration, there were no obvious abnormal reactions in the above observation indicators. 24 hours after the last administration, 1 / 2 of the animals were killed, and the rectum was taken. No obvious changes such as congestion and edema were found in the mucosa. There was no significant difference in pathological histology compared with the control group. After one week of feeding and observation, no one died. The rectum was taken for macroscopic observation and pathological histology, and there was no significant difference compared with the control group. Due to the limitation of drug concentration and administration volume, the dose could not be increased. It shows that after multiple large-dose rectal administration of rabbits, no obvious toxicity and irritation were observed.
[0089] All the above experiments were passed safely.
[0090] Conclusion: The anti-inflammatory and analgesic ointment has no obvious toxicity or irritation and is very safe.
[0091] Mice were selected from Kunming strain mice, 6 weeks old, purchased from the Experimental Animal Research Center of Inner Mongolia University (clean grade, second level, certificate number (Jingdongzi) No. 8806M35).
[0092] The rabbits used were large-eared white rabbits weighing about 2.0 kg, which were supplied by the animal room of Inner Mongolia Medical College.
[0093] The anti-inflammatory and analgesic ointments obtained in Examples 1-3 are A anti-inflammatory and analgesic ointment, B anti-inflammatory and analgesic ointment, and C anti-inflammatory and analgesic ointment, respectively.
[0094] The anti-inflammatory and analgesic ointment prepared by the invention can be used to treat anal diseases such as anal fissure, internal hemorrhoids, mixed hemorrhoids, anal fistula, or postoperative bleeding pain. For external use, the ointment is evenly applied to the affected area, and the patient can change the dressing in time according to the pain time. Under normal circumstances, the dressing is changed once every 1-2 days. A course of treatment for anal fissure, external hemorrhoids, and internal hemorrhoids is ten days, and a course of treatment for mixed hemorrhoids is thirty days; a course of treatment for anal sinusitis and postoperative dressing change is twenty days.
[0095] Case statistics:
[0096] AAnti-inflammatory and analgesic ointment
[0097] 100 cases were treated, among which 58 were male and 42 were female, the oldest was 65 years old and the youngest was 15 years old, and the total effective rate and cure rate were both 100%. The bone injury Chinese medicine ointment of the present invention can exert its efficacy in as fast as 3 minutes after application, and can usually exert its efficacy within 25 minutes, and has a corresponding analgesic effect, effectively alleviating the pain of the patient.
[0098] B Anti-inflammatory and analgesic ointment
[0099] 100 cases were treated, among which 57 were male and 43 were female, the oldest was 67 years old and the youngest was 13 years old, and the total effective rate and cure rate were both 95%. The bone injury Chinese medicine ointment of the present invention can exert its efficacy in as fast as 8 minutes after application, and can usually exert its efficacy within 35 minutes, and has a corresponding analgesic effect, effectively alleviating the pain of the patient.
[0100] C Anti-inflammatory and analgesic ointment
[0101] 100 cases were treated, among which 55 were male and 45 were female, the oldest was 68 years old and the youngest was 12 years old, and the total effective rate and cure rate were both 98%. The bone injury Chinese medicine ointment of the present invention can exert its efficacy in as fast as 5 minutes after application, and can usually exert its efficacy within 30 minutes, and has a corresponding analgesic effect, effectively alleviating the pain of the patient.
[0102] From the treatment of the above cases, we can see that anti-inflammatory and analgesic ointment A has the best therapeutic effect.
[0103] The A anti-inflammatory and analgesic ointment was used in more than 10,000 cases of clinical application, and the results of 1,000 cases of treatment are reported as follows:
[0104] 1000 patients with various anorectal diseases were selected, and the specific classification is shown in the table below:
[0105]
[0106] The treatment results are shown in the table below:
[0107]
[0108] From the above statistical treatment results, it is observed that the anti-inflammatory and analgesic ointment prepared by the present invention has a therapeutic efficacy of 96.54% on anorectal diseases.
[0109] The specific research and development of the present invention is as follows:
[0110] 1. Prescription:
[0111] As shown in the technical solution of the present invention, dragon bone, catechu, borneol, myrrh, frankincense (processed), dragon's blood, gardenia, and ginkgo leaves.
[0112] 2. Manufacturing method:
[0113] 55g of dragon bone, 55g of catechu, 30g of borneol, 25g of myrrh, 30g of frankincense (processed), 35g of blood clotting, 15g of gardenia, and 15g of ginkgo leaf are crushed and processed respectively, and they are crushed into fine powders respectively. They are taken according to the proportion and mixed evenly. The mixed fatty acid glyceride is heated. When it is heated to about 120°C, it is filtered and left to stand or physically cooled. When the temperature of the mixed fatty acid glyceride after heating and filtration drops to about 50°C, the mixed fatty acid glyceride is mixed again with the powder mixed evenly in step 2 according to a certain ratio, and stirred evenly. The mixture of the matrix and the powder mixed and stirred evenly is poured into a plug mold coated with a lubricant and cooled. After cooling, the overflowed part is scraped off, the mold is opened and the plug is taken out, and the production of the anti-inflammatory and analgesic ointment can be completed.
[0114] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. An anti-inflammatory and analgesic ointment, characterized in that: The weight ratio of the medicinal raw materials of the anti-inflammatory and analgesic ointment is: 45-55g of dragon bone, 45-55g of catechu, 20-30g of borneol, 25g of myrrh, 20-30g of frankincense (processed), 25-35g of dragon blood, 10-15g of gardenia, and 10-15g of ginkgo leaf.
2. The anti-inflammatory and analgesic ointment according to claim 1, characterized in that: The weight ratio of the medicinal raw materials of the anti-inflammatory and analgesic ointment is: 50g of dragon bone, 50g of catechu, 25g of borneol, 25g of myrrh, 25g of frankincense (processed), 30g of dragon blood, 10-15g of gardenia, and 10-15g of ginkgo leaf.
3. The anti-inflammatory and analgesic ointment according to claim 1, characterized in that: The weight ratio of the medicinal raw materials of the anti-inflammatory and analgesic ointment is: 50g of dragon bone, 50g of catechu, 25g of borneol, 25g of myrrh, 25g of frankincense (processed), 30g of dragon blood, 12g of gardenia, and 12g of ginkgo leaf.
4. The anti-inflammatory and analgesic ointment according to claim 1, characterized in that: The matrix of the anti-inflammatory and analgesic ointment is mixed fatty acid glyceride.
5. The method for preparing the anti-inflammatory and analgesic ointment according to any one of claims 1 to 4, characterized in that: The steps include: Step 1: grind dragon bone, catechu, borneol, myrrh, frankincense (processed), dragon's blood, gardenia, and ginkgo leaf into fine powder respectively, and set aside for later use; Step 2: Take the eight Chinese medicinal herbs crushed into fine powder in step 1 according to the proportions and mix them evenly; Step 3: Heat the mixed fatty acid glyceride, filter it when it is heated to about 120° C., and place it aside or cool it down physically; Step 4: When the temperature of the mixed fatty acid glyceride after heating and filtration in step 3 drops to about 50° C., the mixed fatty acid glyceride is mixed again with the powder mixed evenly in step 2 according to a certain ratio, and stirred evenly; Step 5: Pour the mixture of the matrix and the powder mixed and stirred evenly in step 4 into the suppository mold coated with lubricant and cool it. After cooling, scrape off the overflowed part, open the mold and take out the suppository, and the production of the anti-inflammatory and analgesic ointment is completed.
6. The method for preparing the anti-inflammatory and analgesic ointment according to claim 5, characterized in that: The mixing ratio of the mixed fatty acid glyceride to the powder uniformly mixed in step 2 is 17:
3.
7. The method for preparing the anti-inflammatory and analgesic ointment according to claim 5, characterized in that: The anti-inflammatory and analgesic ointment prepared in step 5 is an ointment.
